GlobalData warns US tariffs on pulsed field ablation (PFA) systems—now valued at $535.9M—could slow the cardiovascular device market’s 31.7% CAGR through 2034
A study reveals that men adhering to traditional gender norms are less likely to report or receive treatment for cardiovascular risk factors, underscoring the need for early detection